Clinical Trials on Autoimmune Thyroiditis

Total 12710 results

University of Iowa

Completed

Cerebellar tDCS and Balance Training in PwMS

Multiple Sclerosis

United States
Selcuk University

Completed

The Effect of an Interactive Web-based Program in the Management of Multiple Sclerosis

Multiple Sclerosis

Turkey
University of Nottingham

Completed

Providing Emotional Support Around the Point of Multiple Sclerosis Diagnosis: PrEliMS 2 (PrEliMS2)

Multiple Sclerosis

United Kingdom
Genzyme, a Sanofi Company

Active, not recruiting

Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis (TERIKIDS)

Multiple Sclerosis

Belgium, United States, Bulgaria, Canada, China, Estonia, France, Greece, Israel, Lebanon, Lithuania, Morocco, Netherlands, Portugal, Russian Federation, Serbia, Spain, Tunisia, Turkey, Ukraine, United Kingdom
University of Nebraska
Teva Branded Pharmaceutical Products R&D, Inc.

Withdrawn

The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate Injections

Multiple Sclerosis

United States
Mayo Clinic

Enrolling by invitation

A Study of Imaging in Demyelinating Diseases

Multiple Sclerosis | Inflammatory Demyelinating Disease

United States
Bayer

Completed

US PROmyBETAapp2.0: A Study to Learn More About the Medication Usage and Patient Reported Outcomes Via the myBETAapp in Medical Care of Patients With Multiple Sclerosis Treated With BETASERON Using BETACONNECT Autoinjector

Multiple Sclerosis

United States
Bayer

Completed

Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon (BETAPREDICT)

Multiple Sclerosis

Germany
Assistance Publique Hopitaux De Marseille

Active, not recruiting

MRI Study of the Mechanisms Underlying Irreversible Disability in Multiple Sclerosis (SEP-MRI)

Multiple Sclerosis

France
Biogen

Active, not recruiting

A Study Utilising Data From European Union (EU) National Multiple Sclerosis (MS) Registries to Assess the Incidence of Anti-Natalizumab Antibody Among Participants Who Receive Subcutaneous Administration of Natalizumab for Treatment of Relapsing-remitting Multiple Sclerosis (RRMS)

Multiple Sclerosis

United States
University of Jordan

Active, not recruiting

The Effect of Cigarette Smoke on Sleep Quality and Physical Activity in People With Multiple Sclerosis (Smoke-MS)

Multiple Sclerosis

Jordan
Istanbul University - Cerrahpasa (IUC)
Prof.Dr.Mazhar Osman Mental Health and Psychiatric Diseases Education, Research...

Completed

The Effects of Two Different Types of Exercise Programs to Increase Physical Activity in Patients With MS

Multiple Sclerosis

Turkey
University of Ottawa
The Ottawa Hospital; Queen's University; Consortium of Multiple Sclerosis Centers

Completed

A Dyadic Approach for Promoting Physical Activity Among People With MS and Their Support Partners (PAT-MS)

Multiple Sclerosis

Canada
Biruni University

Completed

Proprioceptive Neuromuscular Facilitation in Multiple Sclerosis

Multiple Sclerosis

Turkey
CorEvitas

Enrolling by invitation

Corevitas Multiple Sclerosis (MS) Registry

Multiple Sclerosis

United States
The University of Texas Health Science Center,...

Terminated

Augmenting Cerebral Blood Flow to Treat Established Multiple Sclerosis (perfuseMS)

Multiple Sclerosis

United States
University of Alabama at Birmingham
Patient-Centered Outcomes Research Institute; Lakeshore Foundation; Alabama Neurology...

Completed

Tele-Exercise and Multiple Sclerosis (TEAMS)

Multiple Sclerosis

United States
University of North Texas, Denton, TX
University of Alabama at Birmingham; Berry College

Completed

Feasibility of a High-intensity Interval Training Program in Persons With Multiple Sclerosis Who Have Walking Disability

Multiple Sclerosis

United States
Biogen

Completed

Validation of DigiCog and Konectom Tools to Support Digitalized Clinical Assessment in Multiple Sclerosis (DigiToms)

Multiple Sclerosis

France
Rennes University Hospital

Completed

National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple Sclerosis (MITOX-REBIF)

Multiple Sclerosis

France
Centre Hospitalier Universitaire de Nice

Completed

A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period (TERICIS)

Multiple Sclerosis

France
Merck KGaA, Darmstadt, Germany

Completed

Evaluation of the Onset of Action in Highly Active MS (MAGNIFY)

Multiple Sclerosis

United Kingdom, Germany, Israel, Finland, Canada, Australia, Czechia, Spain, France, Italy, Austria, Hungary, Poland, Sweden
Gazi University

Completed

The Reliability and Validity of the L-test in Patients With Multiple Sclerosis

Multiple Sclerosis

Turkey
Biogen

Terminated

Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis

Multiple Sclerosis

United States, Italy, Switzerland, United Kingdom, Czechia, France
Nigde Omer Halisdemir University
Pamukkale University

Completed

Multiple Sclerosis and Respiratory and Functional Capacity

Multiple Sclerosis

Turkey
Actelion

Completed

Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis (OPTIMUM)

Multiple Sclerosis

United States, Belarus, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Finland, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Latvia, Lithuania, Mexico, Poland, Portugal, Romania, Russian Federation, Serbia, S... and more
BeCare Link LLC
Yale University

Enrolling by invitation

Validation of the BeCare Multiple Sclerosis Assessment App

Multiple Sclerosis

United States
University of Colorado, Denver
EMD Serono; National Multiple Sclerosis Society

Completed

Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study

Multiple Sclerosis

United States
University of California, San Francisco
Genentech, Inc.

Completed

Ocrelizumab in Breastmilk

Multiple Sclerosis | Clinically Isolated Syndrome

United States
Neuromed IRCCS

Completed

Lipid Mediators in Multiple Sclerosis (LipidMediators)

Multiple Sclerosis

Italy
University of Alabama at Birmingham
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Terminated

Activity and Balanced Eating to Reduce Comorbidities and Symptoms of MS (ABC's of MS)

Multiple Sclerosis

United States
Louisiana State University Health Sciences Center...
Biogen

Completed

Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis

Multiple Sclerosis

United States
University of Aarhus
University of Southern Denmark; Region of Southern Denmark

Completed

Early Exercise Efforts in Multiple Sclerosis

Multiple Sclerosis

Denmark
Kahramanmaras Sutcu Imam University

Completed

Figure of 8 Walk Test in Multiple Sclerosis

Multiple Sclerosis

Turkey
Pipeline Therapeutics, Inc.

Completed

PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy Volunteers

Multiple Sclerosis

United Kingdom
The Cleveland Clinic

Active, not recruiting

The Therapeutic Effects of Forced Aerobic Exercise in Multiple Sclerosis

Multiple Sclerosis

United States
National Institute of Neurological Disorders and...

Completed

Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis

Multiple Sclerosis

United States
Multiple Sclerosis Center of Catalonia

Completed

Endurance and Walking Training by Nordic Walking in Multiple Sclerosis

Multiple Sclerosis

Spain
Gazi University

Completed

Relationship of Position Sense With Gait and Balance in Patients With Multiple Sclerosis

Multiple Sclerosis

Turkey
Gazi University

Completed

Clinical Factors Associated With Position Sense in Patients With Multiple Sclerosis

Multiple Sclerosis

Turkey
Hacettepe University

Completed

Investigation of the Effects of Technology Supported Different Physiotherapy Approaches on Patients With Multiple Sclerosis

Multiple Sclerosis

Turkey
Charite University, Berlin, Germany

Completed

Normobaric Hypoxic Training and Multiple Sclerosis (MS_EPOXI)

Multiple Sclerosis

Germany
Pomeranian Medical University Szczecin

Completed

Sensory Integration Disorders in Patients With MS Including Disease Advancement and Relapses in the Last Year

Multiple Sclerosis

Poland
Nantes University Hospital

Completed

Quantifying Gait Alteration in Multiple Sclerosis Using a Wearable Device (eMSGait)

Multiple Sclerosis

France
University Hospital, Grenoble
University Grenoble Alps

Completed

Metacognition Assessment in Patient With Multiple Sclerosis (METACOGSEP)

Multiple Sclerosis

France
Dokuz Eylul University

Completed

Video Game-based Physical Activity Training in People With Multiple Sclerosis During Relapse Treatment

Multiple Sclerosis

Turkey
University of Texas Southwestern Medical Center
Biogen

Completed

Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS) (ARISE)

Multiple Sclerosis (MS)

United States
Biogen

Terminated

Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) (AFFINITY)

Multiple Sclerosis

United States, Italy, Spain, Belgium, Germany, Switzerland, Australia, Hungary, France, Poland, United Kingdom, Czechia, Israel, Canada, Netherlands
Genzyme, a Sanofi Company

Terminated

LEMTRADA Pregnancy Registry in Multiple Sclerosis

Multiple Sclerosis

United States, Australia, Austria, Belgium, Canada, Denmark, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
Kessler Foundation
National Multiple Sclerosis Society

Completed

Applying Speed of Processing Training to Individuals With Multiple Sclerosis (SPTMS)

Multiple Sclerosis

United States

Clinical Trials on Autoimmune Thyroiditis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations